Data Management and Biostatistics

对西非利什曼病的了解有限，包括影响该病的环境因素、媒介唾液在利什曼病中的作用以及其他病原体在这一被忽视疾病发展中的作用。最近在马里和加纳进行的研究使我们能够提出更全面的问题并提出新的假设，以增加我们对皮肤利什曼病在该领域的传播和发展的了解，目的是确定预防和治疗这种被忽视疾病的新方法。该建议的主要具体目标是：了解生活在流行地区的个体对利什曼病发展过程中媒介唾液蛋白的免疫反应的关联，以及重要的是，这些免疫反应如何通过与丝虫病的共同感染来调节。这些研究结果将有助于指导基于唾液腺蛋白的疫苗开发。行政核心的长期目标是：1]为每个相关机构发展研究管理方面的专业知识；2]在与卫生研究有关的行政问题上提供领导；3]为个人培训（能力建设）做出贡献，以确保与其他热带医学研究中心就被忽视的热带病进行自我维持的研究和网络。更具体地说，行政核心将跟踪每个单独项目和核心的科学进展和成就；2]确定并确保在不同现场和实验室进行相关研究的协调；3]确保符合irb和其他监管机构对人类受试者研究的要求；4]制定行政指导方针，界定调查人员的责任，并确保负责地管理为这些研究提供的资金。

There is limited knowledge of leishmaniasis in West Africa including the environmental factors affecting this disease, the role of vector saliva in leishmaniasis and the role of other pathogens in the development of this neglected disease. Recent studies in Mali and Ghana enabled us to formulate more comprehensive questions and propose new hypothesis to increase our understanding of the transmission and development of cutaneous leishmaniasis in the field with the objective to identify novel ways to prevent and treat this neglected disease. The major specific aim of this proposal is to: understand the association of immune responses of individuals living in endemic areas to vector salivary proteins in the development of leishmaniasis and importantly, how these immune responses may be modulated by co-infections with filarial worms. Findings of these study will contribute to guide vaccine development based on salivary gland proteins. The long-term objectives of the Administrative Core are to: 1] develop expertise in research administration for each institution involved, 2] provide leadership on administrative issues related to health research, and 3] to contribute in the training of individuals (capacity building) to ensure self-sustaining research and networks on neglected tropical diseases with other Tropical Medicine Research Center. More specifically, the administrative core will 1] Track scientific progress and accomplishments for each of the individual projects and cores; 2] Identify and ensure the coordination of related studies at different field sites and laboratories; 3] Ensure compliance with IRBs and other regulatory authorities for studies of human subjects; 4] Develop administrative guidelines to define the responsibilities of investigators, and to ensure the responsible management of funds provided for these studies.